Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Dosing Structure: Loading Phase vs Maintenance

The standard men 25-35 TB-500 protocol follows a two-phase structure: loading and maintenance. Loading doses typically range from 5–10mg total per week, split into two injections of 2.5–5mg each, administered 3–4 days apart. This phase lasts 2–4 weeks dependin

This comparison does not assign a generated winner or score.

  • The standard men 25-35 TB-500 protocol follows a two-phase structure: loading and maintenance. Loading doses typically range from 5–10mg total per week, split into two injections of 2.5–5mg each, administered 3–4 days apart. This phase lasts 2–4 weeks depending on injury severity and response. The goal is to saturate tissue repair pathways quickly. TB-500's half-life of approximately 10 days means steady-state plasma levels aren't reached until week two under weekly dosing alone, which delays clinical effects.
  • Maintenance dosing drops to 2–2.5mg once weekly after the loading phase. At this level, circulating TB-500 sustains angiogenesis and actin regulation without overstimulating pathways that lead to diminishing returns. Men using TB-500 for chronic tendinopathy or post-surgical recovery typically maintain this dose for 4–6 additional weeks. The peptide's systemic distribution means you don't need to inject directly into the injury site. Subcutaneous administration in the abdomen, thigh, or deltoid delivers identical results.
  • Timing matters as much as dose. We've observed measurably better outcomes when the loading phase coincides with the inflammatory phase of injury (days 1–7 post-trauma) rather than starting weeks later during the remodelling phase. TB-500's actin-binding mechanism is most effective when cellular migration is actively occurring. Starting too late means you're dosing during collagen cross-linking, a phase where actin dynamics play a smaller role. For men using TB-500 as a training adjunct rather than acute injury treatment, the loading phase should align with high-volume training blocks where microtrauma accumulates.
  • Reconstitution protocol: TB-500 arrives as lyophilised powder and must be mixed with bacteriostatic water before injection. Use 2mL bacteriostatic water per 5mg vial. This yields a concentration of 2.5mg/mL, making dose measurement straightforward. Inject the water slowly down the side of the vial to avoid foaming, which can denature the peptide. Once reconstituted, store at 2–8°C and use within 30 days. Any temperature excursion above 8°C risks protein degradation. A single overnight thaw renders the vial useless, even if it looks unchanged.
More references

Related material